Andra AP fonden Trims Position in Henry Schein, Inc. (NASDAQ:HSIC)

Andra AP fonden lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 38.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 60,900 shares of the company’s stock after selling 38,046 shares during the quarter. Andra AP fonden’s holdings in Henry Schein were worth $3,904,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. LGT Group Foundation grew its position in Henry Schein by 21.9% in the 2nd quarter. LGT Group Foundation now owns 192,770 shares of the company’s stock valued at $12,357,000 after buying an additional 34,579 shares during the last quarter. Quest Partners LLC purchased a new stake in shares of Henry Schein in the second quarter valued at about $177,000. Acadian Asset Management LLC increased its stake in shares of Henry Schein by 10.2% during the second quarter. Acadian Asset Management LLC now owns 3,757 shares of the company’s stock worth $240,000 after acquiring an additional 348 shares during the period. National Bank of Canada FI raised its holdings in Henry Schein by 15.5% during the second quarter. National Bank of Canada FI now owns 43,769 shares of the company’s stock worth $2,850,000 after purchasing an additional 5,860 shares in the last quarter. Finally, Versor Investments LP acquired a new stake in Henry Schein in the second quarter valued at about $527,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the topic of several recent analyst reports. Evercore ISI dropped their target price on Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a research report on Wednesday, August 7th. JPMorgan Chase & Co. dropped their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Barrington Research reduced their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. UBS Group lowered their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Finally, Robert W. Baird reduced their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and an average price target of $77.10.

Insider Activity at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

Shares of HSIC opened at $67.05 on Thursday. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63. The stock has a market cap of $8.50 billion, a P/E ratio of 22.65, a PEG ratio of 1.93 and a beta of 0.86. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average of $68.99 and a two-hundred day moving average of $70.68.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. Henry Schein’s revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 EPS. As a group, research analysts predict that Henry Schein, Inc. will post 4.75 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.